SCHEMBL14036646

SCHEMBL14036646

CC1=C(CI)CC(C(C)C)C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7511449 0.71
SCHEMBL20005032 0.69
SCHEMBL19575608 0.63
Alpha-Phellandrene SCHEMBL159518 0.61 USP2 (0.32)
Alpha-Phellandrene SCHEMBL159519 0.61 USP2 (0.32)
Alpha-Phellandrene SCHEMBL19816252 0.60 USP2 (0.31)
SCHEMBL31255976 0.57
SCHEMBL440040 0.56 TLR4 (0.33)
SCHEMBL11702186 0.56 NFKB1 (0.31)
SCHEMBL23717953 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008137102-A2 METHODS OF MODULATING AMYLOID BETA AND COMPOUNDS USEFUL THEREFOR TORREYPINES THERAPEUTICS, INC. (US) 2008-11-13 WO disclosed